Precision and Future Medicine10.23838/pfm.2020.0003020204137-42Non-vitamin K oral antagonist failure and tailored treatment in patients with atrial fibrillation and strokeHyung Jun Kim, Soyoun Choi, Hee-Jin Kim, Oh Young Bang,,
Treatment of Non-vitamin K Antagonist Oral Anticoagulants10.1007/978-981-10-1878-7_120161-10Secondary Prevention of Stroke with Atrial Fibrillation by New Oral AnticoagulantsK. Kamiyama, T. Osato, H. Nakamura
Heart Rhythm10.1016/j.hrthm.2017.01.0252017144606-607Benefits of non–vitamin K antagonist oral anticoagulants in patients with atrial fibrillation go beyond stroke preventionJay A. Montgomery, Gregory F. Michaud,
Journal of Stroke10.5853/jos.2019.019702019213259-275Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial FibrillationKeun-Sik Hong,,
Atrial Fibrillation Therapy10.1007/978-1-4471-5475-4_3201355-89Novel Oral Anticoagulants for Stroke Prevention in Patients with Non-valvular Atrial FibrillationYoseph Rozenman, Yuri Gluzman
Treatment of Non-vitamin K Antagonist Oral Anticoagulants10.1007/978-981-10-1878-7_2201611-23Recurrence of Stroke in Patients with AF Using NOACsYasushi Ueno
Journal of Stroke10.5853/jos.2016.000522016182169-178Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral AnticoagulantsOh Young Bang, Keun-Sik Hong, Ji Hoe Heo,,
Clinical Interventions in Aging10.2147/cia.s8064120151431Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulantsGreg Flaker, Mohit K. Turagam, Poonam Velagapudi
Treatment of Non-vitamin K Antagonist Oral Anticoagulants10.1007/978-981-10-1878-7_7201677-89New Approaches for the Secondary Prevention of Cryptogenic Stroke Using Non-vitamin K Antagonist Oral AnticoagulantsTomohisa Nezu, Yoshiki Yagita
10.1007/978-981-10-1878-72017Treatment of Non-vitamin K Antagonist Oral Anticoagulants,